Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea

Clinical trial NCT01016782 · COMPLETED

Trial details

NCT number: NCT01016782
Sponsor: Fougera Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Inflammatory Rosacea

Start date: 2008-01-01
Primary completion: 2009-07-01
Enrollment: 867

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.